- Berylliosis
- Bronchiolitis obliterans organizing pneumonia (BOOP)
- Hypersensitivity pneumonitis
- Idiopathic pulmonary fibrosis
- Interstitial lung disease (ILD)
- Langerhans cell histiocytosis
- Lupus related interstitial lung disease
- Lymphoid interstitial pneumonia (LIP)
- Organizing pneumonia
- Polymyositis interstitial lung disease
- Pulmonary fibrosis
- Pulmonary sarcoidosis
- Rheumatoid arthritis interstitial lung disease
- Scleroderma interstitial lung disease
Kathryn Flack, MD
About me
- Assistant Professor of Clinical Medicine (Pulmonary, Allergy and Critical Care)
My education and training
- Medical School: Mount Sinai Medical Center
- Residency: University of Pennsylvania Health System
- Fellowship: University of Pennsylvania Health System
Spoken languages
Insurance accepted
- Aetna Advantra Cares D-SNP
- Aetna Advantra Credit Value
- Aetna Advantra Eagle HMO
- Aetna Advantra Eagle POS
- Aetna Advantra Premier Plus PPO
- Aetna Advantra Value
- Aetna Advantra Value Plus
- Aetna APCN Plus (Multi-Tier)
- Aetna Better Health Kids (CHIP) - DH Only
- Aetna Flexible Five
- Aetna Freedom Core
- Aetna Gold
- Aetna HMO
- Aetna Philly Prime
- Aetna POS
- Aetna PPO APCN
- Aetna Premier
- Aetna Premier Plus
- Aetna Savings Plus
- Aetna Signature Administrators
- Aetna Student Health Plan PPO
- Aetna Upfront Advantage
- First Health HMO
- First Health POS
- First Health PPO
- Meritain - Aramark (Other)
- Meritain - Aramark (Pennsylvania Premier Medical Plan)
- Americhealth Caritas of PA VIP - LGH Only
- Amerihealth Caritas (Transplant patients only)
- Amerihealth Caritas of PA - LGH Only
- Centivo EPO
- Cigna Healthcare EPO
- Cigna Healthcare HMO
- Cigna Healthcare POS
- Cigna Healthcare PPO
- Claim Watcher (Homestead/ INDECs) Open Access
- Clover Health Choice
- Clover Health Choice Value PPO
- Clover Health Classic HMO
- Clover Health Value
Locations
Penn Medicine hospital privileges
- Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
- Pennsylvania Hospital: Has privileges to treat patients in the hospital.
- Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
- Penn Medicine Rittenhouse Long-Term Acute Care Hospital
Qualifications and experience
- Critical Care Medicine, 2025
- Pulmonary Disease, 2022
- Internal Medicine, 2019
- American Thoracic Society, Member, International
- Society of Critical Care Medicine, Member, National
Treatments and conditions
Research
Publications
Flack KF, George MD, Kim JS, Hsu JY, Podolanczuk AJ, Hoffman E, Johnson C, McGroder CF, Smith, BM, Kreider ME, Kawut SM, Barr RG, Anderson MR, Bernstein EJ. Antinuclear antibodies and progression of quantitative interstitial lung changes: The Multi-Ethnic Study of Atherosclerosis (MESA)-Lung Study. , Respiratory Medicine: 2025
Ramadurai D, Flack K, Wu L, Kass-Gergi S, Heath J, Kreider M, Dine CJ, Secunda K. Coordinator-implemented algorithm for identifying spirometric progression to screen for progressive pulmonary fibrosis clinical trials. , ATS Scholar: 2025
Kim JS, Flack KF, Malik V, Manichaikul A, Sakaue S, Luo Y, Anderson MR, Hoffman EA, Podolanczuk AJ, Yun J, McDermott G, Sparks JA, Moll M, Rich S, Rotter J, Noth I, Raghu G, Giles J, Winchester R, Raychaudhuri S, Hunninghake GM, Cho MH, Garcia CK, Barr RG, Bernstein EJ Genomic and Serological Rheumatoid Arthritis Biomarkers, MUC5B Promoter Variant, and Interstitial Lung Abnormalities , Ann Am Thorac So : 2024
Friedman Flack K, George M, Podolanczuk A, Kim J, Hoffman E, Johnson C, McGroder C, Smith B, Garcia C, Kreider M, Kawut S, Barr R.G, Anderson M, Bernstein E. Antinuclear antibodies and progression of high attenuation areas on chest computed tomography: the Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study. , American Thoracic Society: 2023
Friedman Flack K & Katzen J. Revealing the rare: Pulmonary fibrosis from surfactant-related gene mutation. , CHEST., 163(4): 2023,744-745
Kim J, Flack K, Malik V, Manichaikul A, Sakaue S, Luo Y, Anderson M, Hoffman E, Podolanczuk A, Yun J, McDermott G, Sparks J, Moll M, Rich S, Rotter J, Noth I, Ragu G, Giles J, Winchester R, Raychaudhuri S, Hunninghake G, Cho M, Garcia C, Barr R.G, Bernstein E. Association of rheumatoid arthritis-related antibodies, HLA-DRB1, and MUC5B (rs35705950) with high attenuation areas, forced vital capacity, and interstitial lung abnormalities. , International Colloquium on Lung and Airway Fibrosis : 2022
Friedman Flack, K., Gao, G.M., Berstein, E., Johnson, C., Diamond, J., Benvenuto, L. Arcasoy, S., Greeland, J., Betancourt, L., Oyster, M., Brown, M., Kalman, L., Zaleski, D., Adler, J., Tevald, M., Balar, P., Patel, S., Medikonda, N., Kreider, M., Christie, J., Singer, J., Anderson, M. Differences in body composition and frailty between lung transplant candidates with connective tissue disease-related interstitial lung disease and idiopathic pulmonary fibrosis. , American Thoracic Society: 2022
Friedman Flack K, Grimm J, Haas A, Jarrar D, Szeto W, Palevsky H. Massive hemoptysis secondary to an aortomediastinoparenchymal fistula. , American Thoracic Society International Conference. : 2020
Friedman Flack K, Chu S, Ciunci C, Berman A, Kreider M, Porteous M. The management and outcomes of patients with both interstitial lung disease and lung cancer. , American Thoracic Society International Conference. Dallas, TX: 2019
Kolb JM*, Friedman Flack K*, Chatterjee-Murphy P, Desai J, Wallentin L, Ezekowitz M, Connolly S, Reilly P, Brueckmann M, Ilgenfritz J, Aisenberg J., *co-first authors Locations and mucosal lesions responsible for major gastrointestinal bleeding in patients on warfarin or dabigatran. , Dig Dis Sci. , 63(7): 2018,1878-1889